Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

17.00
Delayed Data
As of Dec 15
 +0.25 / +1.49%
Today’s Change
9.30
Today|||52-Week Range
17.70
+25.46%
Year-to-Date
New Strong Buy Stocks for December 14th
Dec 14 / Zacks.com - Paid Partner Content
Incyte (INCY) Reports Phase III Follow-Up Data for Jakafi
Dec 11 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Report Positive Top Line Skin Cancer Data
Dec 13 / Zacks.com - Paid Partner Content
3 Drug/Biotech Stocks Up More Than 10% This Week
Dec 08 / Zacks.com - Paid Partner Content
3 Drug/Biotech Stocks Up More Than 10% This Week
Dec 13 / Zacks.com - Paid Partner Content
Roche Reports Tecentriq/Avastin Lung Cancer Study Data
Dec 07 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Reports Positive Data on Leukemia Drug
Dec 12 / Zacks.com - Paid Partner Content
Sucampo Pharmaceuticals (SCMP) in Focus: Stock Moves 5.6% Higher
Dec 06 / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Sickle Cell Disease Drug
Dec 12 / Zacks.com - Paid Partner Content